Longitudinal observation of solitary fibrous tumor translation into malignant pulmonary artery intimal sarcoma
Journal of Cardiothoracic Surgery volume 15, Article number: 233 (2020)
Pulmonary artery intimal sarcoma (PAIS) is a rare malignant tumor that was usually misdiagnosed as chronic pulmonary thromboembolism.
We previously reported a solitary fibrous tumor in the pulmonary artery presented with acute pulmonary embolism, which was identified by 99mTc-Galacto-RGD2 imaging. However, this patient had a recurrence in situ two-year after surgery, post-operative pathology revealed pulmonary artery intimal sarcoma. At one-year post-operation, 18F-FDG PET/CT was performed for exclusion of tumor metastasis, which showed FDG avid lesion in the T5, T10, and L5 vertebral bodies, as well as in bilateral ilium and right ischium.
This is the first longitudinal observation of a solitary fibrous tumor (SFT) development into a pulmonary artery intimal sarcoma (PAIS) and presented with multiple bone metastases.
Pulmonary artery intimal sarcoma (PAIS) is a rare malignant tumor that may be misdiagnosed as chronic pulmonary thromboembolism [1, 2]. We previously reported a solitary fibrous tumor in the pulmonary artery presented with acute pulmonary embolism, which was identified by 99mTc-Galacto-RGD2 imaging . However, this patient had a recurrence in situ two-year after surgery, post-operative pathology revealed pulmonary artery intimal sarcoma. This is the first longitudinal observation of a solitary fibrous tumor (SFT) development into a pulmonary artery intimal sarcoma (PAIS) and presented with multiple bone metastases.
The 70-year-old female patient we previously reported with pulmonary solitary fibrous tumors (SFT), presented with increasingly aggravated oppression in chest but released after rest. Transthoracic echocardiography revealed a 43.7 mm × 15.9 mm solid echo-level mass which attached to the lower part of the main pulmonary artery and the beginning of left pulmonary artery, no significant blood stream was seen in the left pulmonary artery, whereas partial blood stream passed the right pulmonary artery. Ultrasonic spectroscopy found the velocity of blood flow of tricuspid valve was 4.3 m/s, which was turbulent flow (Fig. 1). Chest CT showed partial higher density shadow of pulmonary trunk and left branch (Fig. 2). Herein, after cardiopulmonary bypass was established, the aorta was opened and the mass was carefully resected. The surface of the mass was smooth, white and elastic and attached to the main pulmonary artery and bilateral pulmonary artery. The hematoxylin and eosin (H&E) staining showed the majority of cells were proliferating spindle cells with significant heterogeneity and interspersed vessel branching. Immunohistochemical analysis (ICH) showed: CD34(3+), CD99(−), SMA(−), d2–40(+), SOX10(−), NF(−) STAT6(±), CK(−), Ki-67(10%) S-100(−), compared with first post-operative surgery, spindle cell showed more atypia and higher expression of CD34 (Fig. 3). These pathological findings revealed that recurrent lesion was artery intimal sarcoma. At one-year post-operation, 18F-FDG PET/CT was performed for exclusion of tumor metastasis, which showed FDG avid lesion in the T5, T10, and L5 vertebral bodies, as well as in bilateral ilium and right ischium (Fig. 4).
PAIS grows within the lumen of pulmonary arteries and eventually occludes those vessels. Common symptoms of primary pulmonary arterial sarcoma include dyspnea, chest pain, edema, cough, and hemoptysis [4, 5], it mimics pulmonary embolism (PE), which is characterized by pulmonary artery luminal narrowing or occlusion in computer tomography (CT) . How to diagnose the tumor originated from pulmonary artery accurately is great challenge in the clinical, because of insidious onset and symptoms indistinguishable from pulmonary thromboembolic diseases.
This rare case had relapse of chest oppression because of pulmonary artery intimal sarcoma, who was previously diagnosed as solitary fibrous tumor after the first surgery. Echocardiography reflected blood stream, calcification and blood velocity, which was useful for the detection of PAIS. 18F-FDG image showed multiple hyper-metabolic lesions consistent with lytic bone changes after the second surgery. Several case reports validated 18F-FDG PET/CT had some merits in the diagnosis of mesenchymal derived sarcomas,18F-FDG uptake in the higher-grade sarcoma correlated with mitotic count and grade [5,6,7,8]. The second post-operative pathology showed much more atypia and heterogeneity, significantly higher expression of CD34, which is hallmark of neo-vasculature, the proliferation index of Ki-67 increased as well.
This is the first report of longitudinal observation of SFT development into a PAIS with multiple bone metastases. Till now, the mechanism of tumor initiation, development and metastasis is not fully elucidated, the biological behavior is not fully identified, which is really great challenge in the oncology. Nuclear medicine and molecular imaging can describe tumor metabolism, receptor expression and angiogenesis, which serves as valuable surrogates of metastasis and prognosis. Integrin αvβ3 overexpressed on activated endothelial cells, and medicated tumor growth, local invasiveness and metastatic potential. In this case, if antitumor treatment was given after second operation, maybe the multiple metastasis can be avoided, which has been observed in the well differentiated neuroendocrine tumor. If patient was examined on time with 99mTc-Galacto-RGD2 SPECT/CT and 18F-FDG PET/CT, metastatic lesions would be found earlier than morphological changes. 99mTc-Galacto-RGD2 SPECT/CT was critical in the diagnosis of SFT, and further revealed metastatic potential and angiogenesis which led to development and metastasis. Therefore, we recommend that patient undergoes systemic evaluation of preoperative 99mTc-Galacto-RGD2 SPECT/CT, and necessary nuclear medicine and molecular imaging after surgery to early detect the metastasis. However, whether to perform systematic treatment, it is worthy of further discussion. This longitudinal observation of SFT development and progression to malignant pulmonary artery intimal sarcoma, which sheds light on tumor development and metastasis.
Intimal sarcoma of the pulmonary artery is a rare malignant tumor that may be developed from solitary fibrous tumor, which sheds light on the mechanism of tumor development and metastasis. 99mTc-Galacto-RGD2 SPECT/CT and 18F-FDG PET/CT, may evaluate the biological behavior and prognosis. This case report addresses SFT development into a PAIS with multiple bone metastases.
Availability of data and materials
Sanada TJ, Sakao S, Naito A, et al. Characterization of pulmonary intimal sarcoma cells isolated from a surgical specimen: in vitro and in vivo study. PLoS One. 2019;14(3):e214654.
Bandyopadhyay D, Panchabhai TS, Bajaj NS, et al. Primary pulmonary artery sarcoma: a close associate of pulmonary embolism-20-year observational analysis. Journal Thorac Dis. 2016;8(9):2592–601.
Luo R, Xu H, Zhang P, et al. Rare solitary fibrous tumor in the pulmonary artery mimicking pulmonary embolism. Circ Cardiovasc Imaging. 2017;10(5):e005933.
Macpherson RE, Pratap S, Tyrrell H, et al. Retrospective audit of 957 consecutive 18F-FDG PET–CT scans compared to CT and MRI in 493 patients with different histological subtypes of bone and soft tissue sarcoma. Clin Sarcoma Res. 2018;8(1):1–12.
Rakheja R, Makis W, Skamene S, et al. Correlating metabolic activity on 18F-FDG PET/CT with histopathologic characteristics of osseous and soft-tissue sarcomas: a retrospective review of 136 patients. AJR Am J Roentgenol. 2012;198(6):1409–16.
Schwarzbach MHM, Hinz U, Dimitrakopoulou-Strauss A, et al. Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas. Ann Surg. 2005;241(2):286–94.
Herrmann K, Benz MR, Czernin J, et al. 18F-FDG-PET/CT imaging as an early survival predictor in patients with primary high-grade soft tissue sarcomas undergoing neoadjuvant therapy. Clin Cancer Res. 2012;18(7):2024–31.
Evilevitch V, Weber WA, Tap WD, et al. Reduction of glucose metabolic activity is more. Accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomas. Clin Cancer Res. 2008;14(3):715–20.
We would like to thank Dr. Pingyang Zhang and Dr. Linlin Wan for echocardiography and image interpretation, and appreciate for patient’s provision of her patient history.
This study was funded by research grants from Nanjing Medical Science and Technology Grant (grant number YKK17109).
Ethics approval and consent to participate
This article does not contain any studies with human participants or animals performed by any of the authors.
Consent for publication
Informed written consent was obtained from the patient. The ethical committee of Nanjing First Hospital waives additional approval for case reports from clinical practice.
All the authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Luo, R., Jiang, Y., Huang, Y. et al. Longitudinal observation of solitary fibrous tumor translation into malignant pulmonary artery intimal sarcoma. J Cardiothorac Surg 15, 233 (2020). https://doi.org/10.1186/s13019-020-01271-3